Skip to Main Content

Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy (PTSD)

Conditions

Diseases of the Nervous System | Mental Health & Behavioral Research

Phase II

What is the purpose of this trial?

The purpose of this study is to combine a single infusion of Ketamine with 7-days of trauma focus psychotherapy to relieve post traumatic stress disorder (PTSD) symptoms more effectively. This treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur.

  • Ages
    21 years - 70 years
  • Gender
    Both
Find out more about who can participate in this trial
  • Trial with
    Yale University School of Medicine
  • Start Date
    03/10/2016
  • End Date
    11/01/2018

For more information about this study, contact:

Charles Gordon

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Sub-Investigators

  • Last Updated
    07/15/2021
  • Study HIC
    #1509016530

Contact Information

For more information about this study, including how to volunteer, contact Charles Gordon

Volunteer Now